"Preparing for the Discontinuation of a Popular Asthma Inhaler in January"
Starting January 1, the asthma medication 'Flovent' will be discontinued by manufacturer GSK due to financial losses when selling to Medicaid. An authorized generic version, Fluticasone, with the same active ingredient will replace it, but it may not be as widely covered by insurance. Health care providers in Rockford, Illinois, are preparing for the transition and urging patients to be proactive, especially during the respiratory virus season. The CDC reports significant numbers of adults and children with asthma in Illinois, highlighting the potential impact of this change.